Somatostatin and propranolol for the treatment of small-for-size syndrome after liver transplantation

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 5, 2008, Pages 560-

  Izden, Ölgin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Liver; Liver transplantation; Living donor

Indexed keywords

PROPRANOLOL; SOMATOSTATIN;

ARTERY LIGATION; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG EFFICACY; GRAFT FAILURE; GRAFT PERFUSION; HUMAN; LETTER; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR LIVER TRANSPLANTATION; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; POSTOPERATIVE COMPLICATION; SMALL FOR SIZE GRAFT SYNDROME;

CARDIOVASCULAR AGENTS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; ORGAN SIZE; PROPRANOLOL; SOMATOSTATIN; SYNDROME;

EID: 53549092270     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-008-1375-1     Document Type: Letter

References (4)

1. Imura S, Shimada M, Ikegami T, Morine Y, Kanemura H. Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:102-110.
2. Garcia-Taso G, Sanyal AJ, Grace ND, Carey WD; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007;102:2086-2102.
3. Xu X, Man K, Zheng SS, Liang TB, Lee TK, Ng KT, et al. Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival. Liver Transpl 2006;12:621-627.
4. Ozden I, Kara M, Pinarbasi B, Salmaslioglu A, Yavru A, Kaymakoglu S, et al. Somatostatin and propranolol to treat small-for-size syndrome that occurred despite splenic artery ligation. Exp Clin Transplant 2007;5:686-689.